Evidence map›Paper›PMID 32962519›Full record

ArticleVirulence2020

Identification and validation of a novel anti-virulent that binds to pyoverdine and inhibits its function.

Xu Wang, Quinn Kleerekoper, Alexey V Revtovich, Donghoon Kang, Natalia V Kirienko

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Virulence, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Screening of Natural Compounds as Inhibitor of MCurrent pharmaceutical design · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Xu WangDepartment of BioSciences, Rice University , Houston, TX, USA.
Quinn KleerekoperShared Equipment Authority, Rice University , Houston, TX, USA.
Alexey V RevtovichDepartment of BioSciences, Rice University , Houston, TX, USA.
Donghoon KangDepartment of BioSciences, Rice University , Houston, TX, USA.ORCID 0000-0001-5314-0961
Natalia V KirienkoDepartment of BioSciences, Rice University , Houston, TX, USA.ORCID 0000-0002-1537-4967
Rice University · US

Funding

Regulation of mitochondrial surveillanceR35GM129294 · NIGMS · RICE UNIVERSITY · PI Natasha Kirienko · 2018 to 2026
$3.6M
Mechanisms of Stimulating Innate ImmunityK22AI110552 · NIAID · RICE UNIVERSITY · PI KIRIENKO, NATASHA · 2015 to 2016
$268k
NIAID NIH HHS K22 AI110552NIGMS NIH HHS R35 GM129294
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAnti-Bacterial AgentsBronchiCaenorhabditis elegansComputer SimulationEpithelial CellsHigh-Throughput Screening AssaysHumansMolecular Docking SimulationMolecular Dynamics SimulationOligopeptidesPseudomonas aeruginosaStructure-Activity RelationshipVirulence FactorsAnti-Bacterial AgentsOligopeptidespyoverdinVirulence Factorsin silico structure modelingPseudomonas aeruginosa (P. aeruginosa)pyoverdinesolution nuclear magnetic resonance (NMR)structure-activity relationship (SAR)

Identifiers

PMID32962519
PMCPMC7549923
OpenAlexW3088758856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.